NEO-MEDROL Drug Patent Profile
✉ Email this page to a colleague
When do Neo-medrol patents expire, and what generic alternatives are available?
Neo-medrol is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in NEO-MEDROL is methylprednisolone acetate; neomycin sulfate. There are forty drug master file entries for this compound. Additional details are available on the methylprednisolone acetate; neomycin sulfate profile page.
Summary for NEO-MEDROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Clinical Trials: | 120 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEO-MEDROL at DailyMed |
Recent Clinical Trials for NEO-MEDROL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 4 |
Northwestern University | Phase 4 |
Rush University Medical Center | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for NEO-MEDROL
US Patents and Regulatory Information for NEO-MEDROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | NEO-MEDROL | methylprednisolone; neomycin sulfate | OINTMENT;OPHTHALMIC | 060645-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | NEO-MEDROL ACETATE | methylprednisolone acetate; neomycin sulfate | CREAM;TOPICAL | 060611-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | NEO-MEDROL ACETATE | methylprednisolone acetate; neomycin sulfate | CREAM;TOPICAL | 060611-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |